{"id":16171,"date":"2026-10-18T15:42:57","date_gmt":"2026-10-18T15:42:57","guid":{"rendered":"https:\/\/medical-article.com\/?p=16171"},"modified":"2026-10-18T15:42:57","modified_gmt":"2026-10-18T15:42:57","slug":"startup-omass-secures-310m-to-advance-drug-for-rare-endocrine-disorder","status":"publish","type":"post","link":"https:\/\/medical-article.com\/?p=16171","title":{"rendered":"Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder"},"content":{"rendered":"<p><a href=\"https:\/\/medcitynews.com\/2026\/10\/startup-omass-rare-disease-endocrine-hormone-melanocortin-2-mc2-cah\/\"><\/a><\/p>\n<p>OMass\u2019s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But Vertex Pharmaceuticals could also compete with a drug candidate from a recent acquisition. <\/p>\n<p>The post <a href=\"https:\/\/medcitynews.com\/2026\/10\/startup-omass-rare-disease-endocrine-hormone-melanocortin-2-mc2-cah\/\">Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder<\/a> appeared first on <a href=\"https:\/\/medcitynews.com\/\">MedCity News<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>OMass\u2019s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But Vertex Pharmaceuticals could also compete with a drug candidate from a recent acquisition. The post Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder appeared first on MedCity&#8230;<\/p>\n","protected":false},"author":0,"featured_media":16172,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-16171","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicine"],"_links":{"self":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/16171"}],"collection":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=16171"}],"version-history":[{"count":0,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/16171\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/media\/16172"}],"wp:attachment":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=16171"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=16171"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=16171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}